Immune Pharmaceuticals

About:

Immune Pharmaceuticals applies a personalized approach to treatment and developing novel antibody therapeutics.

Website: http://immunepharmaceuticals.com/

Twitter/X: danteperbiotech

Description:

Immune Pharmaceuticals Inc. (NASDAQ OMX First North Premier: IMNP; OTCQX: IMNP,) applies a personalized approach to treatment, developing novel, highly targeted antibody therapeutics to improve the lives of patients with inflammatory diseases and cancer. The company’s lead product candidate, Bertilimumab, is entering Phase II clinical studies for moderate-to-severe ulcerative colitis and bullous pemphigoid, with additional studies planned for Crohn’s disease and severe asthma.